Patient info

Osigraft – patient leaflet, side effects, dosage

Medicine status: No longer supplied Details

Medicine strength:
3.3 mg
Contains active substance:
Similar medicines:

Patient leaflet - Osigraft

Facts about Osigraft

Active substance Eptotermin alfa
Strength 3.3 mg
Pharmaceutical form Prolonged-release intraosseous implantation suspension
How is it taken Intraosseous
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. M Musculo-skeletal system drugs
    1. M05 Drugs for treatment of bone diseases
      1. M05B Drugs affecting bone structure and mineralization
        1. M05BC Bone morphogenetic proteins
          1. M05BC02 eptotermin alfa

Sources: the NHS Dictionary of Medicines and Devices (dm+d), release 10.3.0 of 26 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.